Schott and Naigai form Pharmaceutical Joint Venture in Japan

The German technology group Schott and the Japanese company Naigai Glass Industry Co, Ltd have founded a joint venture for pharmaceutical packaging activities in Japan effective October 1, 2010. The new company is called Schott Naigai KK and is based in Osaka, Japan, where Naigai has already been operating a production site for many years. The new joint venture will manufacture high-quality vials for the Japanese pharmaceutical industry mainly from Schott’s pharmaceutical tubing glass ‘Fiolax’. “The founding of this joint venture in Japan represents yet another important milestone in our global growth strategy for our core business of

pharmaceutical packaging. With Naigai, we have found a strong partner who shares the same high commitment to quality that Schott has. This will allow us to significantly strengthen our market position inside the world’s second largest pharmaceutical market,” explained Professor Udo Ungeheuer, Chairman of the Board of

Management of Schott AG. “The customers of our new joint venture will benefit from Schott’s global set-up with multiple production sites and an integrated tubing production, in addition to the technological advancements resulting from its broad research and development base,” notes Keisuke Muratsu, President of Naigai. Schott holds 80% of the shares in the joint venture and Naigai owns 20%. Naigai will be shifting its existing vial manufacturing activities over to this company and Schott will be contributing its highly advanced automatic inspection system from Schott. Schott has maintained a presence in Japan since 1966 and currently has three production locations and a sales office there. SI Analytics.